FDA Guides On Bioequivalence Studies And COVID-19

Offers Advice On Protecting Participants In Studies For ANDAs

 
• By Dave Wallace
  
WHITE OAK, MD - JULY 20: A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger/Getty Images)
The FDA has published guidance on COVID-19 considerations for BE studies • Source: Shutterstock (Sarah Silbiger/Getty Images)

More from Archive

More from Generics Bulletin